MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance

Blood. 2013 Sep 26;122(13):2284-5. doi: 10.1182/blood-2013-07-513366.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease Progression
  • Humans
  • Immunoglobulin M
  • Monoclonal Gammopathy of Undetermined Significance / genetics*
  • Monoclonal Gammopathy of Undetermined Significance / pathology
  • Mutation*
  • Myeloid Differentiation Factor 88 / genetics*
  • Prognosis
  • Proportional Hazards Models
  • Risk Factors

Substances

  • Immunoglobulin M
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88